Dapagain-M 10mg/500mg Tablet ER
Marketer
Systopic Laboratories Pvt Ltd
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg)
Overview Dapagain-M 10mg/500mg Tablet ER
Dapagain-M 10mg/500mg Extended-Release tablets combine two medications to manage type 2 diabetes. This dual-action therapy regulates elevated blood glucose, thereby minimizing the risk of severe diabetic complications and contributing to cardiovascular health. Dapagain-M 10mg/500mg ER tablets can be ingested with food, consistently at the same time each day to aid adherence. Dosage is determined by your physician and should never be altered without their consultation; discontinuation may lead to uncontrolled blood sugar, increasing the risk of kidney failure and vision impairment. This medication complements a comprehensive treatment plan, encompassing a balanced diet, regular physical activity, and weight management as recommended by your doctor. Commonly reported side effects encompass pharyngitis, nasal stuffiness, rhinorrhea, cephalalgia, nausea, emesis, and diarrhea. Adequate hydration is crucial to mitigate dehydration. Genital candidiasis may occur in some patients; diligent hygiene practices can help prevent this. Prior to initiating treatment, discuss any kidney or liver dysfunction, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating women must seek medical guidance before use. Limit alcohol consumption as it may amplify side effects. Regular blood glucose monitoring is vital throughout treatment.
Uses of Dapagain-M 10mg/500mg Tablet ER
Managing Type 2 Diabetes
Major Benefits of Dapagain-M 10mg/500mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Dapagain-M 10mg/500mg Extended-Release tablets with food.
Common Side effects of Dapagain-M 10mg/500mg Tablet ER:
- Nausea
- Vomiting
- Diarrhea
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Polyuria
- Flatulence
- Skin rash
- Taste change
- Difficulty in urination
- Hypoglycemia (low blood glucose level)
- Tremors
- Dizziness
- Back pain
- Increased hematocrit
- Decreased creatinine clearance
- Dyslipidemia
How to use Dapagain-M 10mg/500mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Dapagain-M 10mg/500mg Extended-Release tablets with food.
How Dapagain-M 10mg/500mg Tablet ER works:
Dapagliflozin and Metformin, combined as Dapagain-M 10mg/500mg Extended-Release tablets, offer enhanced blood glucose management. Dapagliflozin facilitates glucose excretion via the kidneys, while Metformin reduces hepatic glucose production, slows intestinal glucose uptake, and improves insulin responsiveness. This dual action synergistically improves blood sugar control.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapagliflozin/Metformin extended-release tablets (10mg/500mg) with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Dapagliflozin/Metformin extended-release tablets (10mg/500mg) during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Dapagliflozin/metformin 10mg/500mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
The extended-release combination of dapagliflozin and metformin (10mg/500mg) requires careful consideration in individuals with impaired renal function. Dosage modification of this medication may be necessary. Physician consultation is advised.
LiverCAUTION
The extended-release Dapagain-M 10mg/500mg tablet requires careful administration for individuals with hepatic impairment. Dosage modification of Dapagain-M 10mg/500mg extended-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Dapagain-M 10mg/500mg Tablet ER :
Should you forget to take a Dapagain-M 10mg/500mg extended-release tablet, administer it promptly. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapagain-M 10mg/500mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |





